Kjetil Retterstøl

18.7k total citations
189 papers, 3.7k citations indexed

About

Kjetil Retterstøl is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Kjetil Retterstøl has authored 189 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Surgery, 53 papers in Endocrinology, Diabetes and Metabolism and 35 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Kjetil Retterstøl's work include Lipoproteins and Cardiovascular Health (95 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (40 papers) and Cancer, Lipids, and Metabolism (34 papers). Kjetil Retterstøl is often cited by papers focused on Lipoproteins and Cardiovascular Health (95 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (40 papers) and Cancer, Lipids, and Metabolism (34 papers). Kjetil Retterstøl collaborates with scholars based in Norway, Netherlands and United States. Kjetil Retterstøl's co-authors include Kirsten B. Holven, Leiv Ose, Marit B. Veierød, Martin P. Bogsrud, Per Ole Iversen, Ingunn Narverud, Kathrine J. Vinknes, Liv Mundal, Nadia Mansoor and Stine M. Ulven and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Kjetil Retterstøl

182 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kjetil Retterstøl Norway 33 1.6k 946 742 603 593 189 3.7k
Kirsten B. Holven Norway 37 1.4k 0.9× 700 0.7× 959 1.3× 514 0.9× 611 1.0× 195 4.1k
John H. Contois United States 28 1.6k 1.0× 1.6k 1.7× 535 0.7× 333 0.6× 686 1.2× 49 3.5k
P. Barton Duell United States 33 2.6k 1.6× 1.0k 1.1× 465 0.6× 245 0.4× 745 1.3× 114 4.7k
Jean Bergeron Canada 29 1.3k 0.8× 989 1.0× 479 0.6× 282 0.5× 620 1.0× 80 2.9k
Dilip Rajasekhar Maddirela United States 8 819 0.5× 1.4k 1.5× 956 1.3× 729 1.2× 892 1.5× 11 4.4k
Rafael Carmena Spain 32 2.1k 1.3× 2.1k 2.2× 550 0.7× 329 0.5× 911 1.5× 154 4.6k
Jari Stengård Finland 24 1.6k 1.0× 1.4k 1.4× 670 0.9× 452 0.7× 779 1.3× 52 5.0k
Yuichi Ishikawa Japan 23 1.3k 0.8× 1.1k 1.1× 537 0.7× 400 0.7× 791 1.3× 81 4.0k
Genovefa Kolovou Greece 34 1.4k 0.8× 1.4k 1.5× 685 0.9× 259 0.4× 1.8k 3.0× 247 4.6k
Giacomo Ruotolo United States 36 1.4k 0.9× 2.1k 2.2× 894 1.2× 369 0.6× 1.1k 1.9× 90 4.3k

Countries citing papers authored by Kjetil Retterstøl

Since Specialization
Citations

This map shows the geographic impact of Kjetil Retterstøl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kjetil Retterstøl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kjetil Retterstøl more than expected).

Fields of papers citing papers by Kjetil Retterstøl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kjetil Retterstøl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kjetil Retterstøl. The network helps show where Kjetil Retterstøl may publish in the future.

Co-authorship network of co-authors of Kjetil Retterstøl

This figure shows the co-authorship network connecting the top 25 collaborators of Kjetil Retterstøl. A scholar is included among the top collaborators of Kjetil Retterstøl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kjetil Retterstøl. Kjetil Retterstøl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wisløff, Torbjørn, Liv Mundal, Jannicke Igland, et al.. (2025). Ten-year costs of cardiovascular disease in genetically verified familial hypercholesterolaemia compared with age- and sex-matched controls. European Journal of Preventive Cardiology. 33(3). 372–380.
2.
Bogsrud, Martin P., Kjetil Retterstøl, Elisabeth Kleivhaug Vesterbekkmo, et al.. (2025). Prospective study on breastfeeding, lipid profile and cardiovascular risk markers in women with familial hypercholesterolaemia: study protocol for the FH-FEMINA study. BMJ Open. 15(4). e092208–e092208. 1 indexed citations
4.
Christensen, Jacob J., Kirsten B. Holven, Martin P. Bogsrud, et al.. (2025). Statin use in pregnancy and risk of congenital malformations: a Norwegian nationwide study. European Heart Journal. 47(3). 318–327. 3 indexed citations
5.
Aaseth, Jan, Kjetil Retterstøl, Helge Rootwelt, & Per G. Farup. (2025). Reduction in Remnant Cholesterol in Obese Individuals After Bariatric Surgery with Gastric Bypass or Sleeve Gastrectomy. Nutrients. 17(1). 189–189.
6.
Retterstøl, Kjetil, Ingunn Narverud, Martin P. Bogsrud, et al.. (2024). Adherence to the Healthy Nordic Food Index is associated with reduced plasma levels of inflammatory markers in patients with heterozygous familial hypercholesterolemia. SHILAP Revista de lepidopterología. 58. 38–45. 2 indexed citations
7.
Olsén, Thomas, Kirsten B. Holven, Erik Arnesen, et al.. (2024). Real-world impact of transitioning from one lipoprotein(a) assay to another in a clinical setting. SHILAP Revista de lepidopterología. 19. 100726–100726. 1 indexed citations
8.
Westbye, Alexander B., Sandra Rinne Dahl, Yngve Thomas Bliksrud, et al.. (2024). A sterol panel for rare lipid disorders: sitosterolemia, cerebrotendinous xanthomatosis and Smith-Lemli-Opitz syndrome. Journal of Lipid Research. 66(1). 100698–100698. 2 indexed citations
9.
Olsén, Thomas, Kathrine J. Vinknes, M. Eline Kooi, et al.. (2024). Estimated stearoyl-CoA desaturase activity mediates the associations of total cysteine with adiposity: The Maastricht Study. Journal of clinical lipidology. 19(2). 348–357. 1 indexed citations
10.
Arnesen, Erik, Ida Laake, Marit B. Veierød, & Kjetil Retterstøl. (2024). Saturated fatty acids and total and CVD mortality in Norway: a prospective cohort study with up to 45 years of follow-up. British Journal Of Nutrition. 132(4). 466–478. 3 indexed citations
11.
Khoury, Janette, Ane C. Westerberg, Serena Tonstad, et al.. (2023). Protocol for a 20-year follow-up after a randomized controlled trial of a Mediterranean diet in pregnancy: maternal and offspring risk factors for cardiovascular disease. Frontiers in Pediatrics. 11. 1256815–1256815. 2 indexed citations
12.
Semb, Anne Grete, Elisabeth Kleivhaug Vesterbekkmo, Kjetil Retterstøl, et al.. (2023). PCSK9-hemmere på blå resept for hvem?. Tidsskrift for Den norske legeforening. 143(8). 1 indexed citations
13.
Christensen, Jacob J., Ingunn Narverud, Maija Ruuth, et al.. (2021). Children with familial hypercholesterolemia display changes in LDL and HDL function: A cross‐sectional study. Journal of Internal Medicine. 290(5). 1083–1097. 8 indexed citations
14.
Vesterbekkmo, Elisabeth Kleivhaug, Kjetil Retterstøl, Sigmund A. Anderssen, et al.. (2021). The Long-term Effect of Different Exercise Intensities on High-Density Lipoprotein Cholesterol in Older Men and Women Using the Per Protocol Approach: The Generation 100 Study. SHILAP Revista de lepidopterología. 5(5). 859–871. 5 indexed citations
15.
Hovland, Anders, Ingunn Narverud, Martin P. Bogsrud, et al.. (2020). Subjects with familial hypercholesterolemia have lower aortic valve area and higher levels of inflammatory biomarkers. Journal of clinical lipidology. 15(1). 134–141. 7 indexed citations
16.
Norum, Kaare R., Alan T. Remaley, Helena E. Miettinen, et al.. (2020). Lecithin:cholesterol acyltransferase: symposium on 50 years of biomedical research from its discovery to latest findings. Journal of Lipid Research. 61(8). 1142–1149. 25 indexed citations
17.
Hovland, Anders, Kjetil Retterstøl, Tom Eirik Mollnes, et al.. (2020). Anti-inflammatory effects of non-statin low-density lipoprotein cholesterol-lowering drugs: an unused potential?. Scandinavian Cardiovascular Journal. 54(5). 274–279. 11 indexed citations
18.
Wisløff, Torbjørn, Liv Mundal, Kjetil Retterstøl, Jannicke Igland, & Ivar Sønbø Kristiansen. (2019). Economic evaluation of lipid lowering with PCSK9 inhibitors in patients with familial hypercholesterolemia: Methodological aspects. Atherosclerosis. 287. 140–146. 11 indexed citations
19.
Retterstøl, Kjetil, et al.. (2018). Are PCSK9 Inhibitors Cost Effective?. PharmacoEconomics. 36(9). 1031–1041. 21 indexed citations
20.
Mundal, Liv, et al.. (2015). Patients with familial hypercholesterolaemia are characterized by presence of cardiovascular disease at the time of death. European Heart Journal. 37(17). 1398–1405. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026